Celgene's most recent trend suggests a bearish bias. One trading opportunity on Celgene is a Bear Call Spread using a strike $102.00 short call and a strike $107.00 long call offers a potential 17.37% return on risk over the next 4 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $102.00 by expiration. The full premium credit of $0.74 would be kept by the premium seller. The risk of $4.26 would be incurred if the stock rose above the $107.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Celgene is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Celgene is bearish.
The RSI indicator is at 29.19 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Celgene
Birchview Capital’s Top Healthcare Stock Picks
Sun, 15 May 2016 19:48:11 GMT
5 Stocks We're Never Selling
Sat, 14 May 2016 16:07:00 GMT
Otezla Captures Psoriasis and Psoriatic Arthritis Market Shares
Sat, 14 May 2016 13:08:14 GMT
bluebird bio Inc: Catnapping in Cambridge
Fri, 13 May 2016 02:04:00 GMT
Bristol-Myers/AbbVie Empliciti Gets Approved in the EU
Thu, 12 May 2016 21:43:09 GMT
Also on Market Tamer…
Follow Us on Facebook